Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1644
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18003462 | GROWTH AND SITE-SPECIFIC ORGANIZATION OF MICRO-SCALE BIMOLECULAR DEVICES ON LIVING CELLS | Non-Final OA | The Johns Hopkins University |
| 17160750 | EYELASH COMPOSITIONS CONTAINING SUGAR | Non-Final OA | L'OREAL |
| 18713834 | HAIR TREATMENT METHOD | Non-Final OA | KAO CORPORATION |
| 17918377 | METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES | Non-Final OA | McMaster University |
| 18724716 | Oral Care Compositions and Methods for the Same | Non-Final OA | Colgate-Palmolive Company |
| 17983420 | HUMAN T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA CELL STRAIN AND USE THEREOF | Final Rejection | ZHEJIANG UNIVERSITY |
| 18675021 | PEEL-OFF LIP LINER STAIN | Non-Final OA | Sacheu Beauty Inc. |
| 17907697 | Synthetic Soluble Receptor Mimics and Methods of Use for Treatment of COVID-19 | Non-Final OA | The Wistar Institute of Anatomy and Biology |
| 17998141 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | Non-Final OA | Ionis Pharmaceuticals, Inc. |
| 18559510 | POROUS MEDIA HAVING BIOCIDAL PROPERTIES | Non-Final OA | OBERTHUR FIDUCIAIRE SAS |
| 17640544 | ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF IN RENAL DISEASE | Non-Final OA | Opsidio, LLC |
| 18004400 | CENTRAL NERVOUS SYSTEM DELIVERY OF PSILOCYBIN | Final Rejection | SILO PHARMA, INC. |
| 18017179 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES | Final Rejection | Dyne Therapeutics, Inc. |
| 18005900 | METHODS AND COMPOSITIONS FOR INCREASING IMMUNITY AGAINST CORONAVIRUSES | Non-Final OA | LEYDEN LABORATORIES B.V. |
| 18009601 | FUSION PROTEIN CONTAINING ERYTHROPOIETIN POLYPEPTIDE | Non-Final OA | BICA THERAPEUTICS INC. |
| 17906956 | METHOD FOR CREATING MULTIMERIC IgA ANTIBODY, AND MULTISPECIFIC MULTIMERIC IgA ANTIBODY | Non-Final OA | JAPAN as represented by DIRECTOR GENERAL of National Institute of Infectious Diseases |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy